Merck changes French set-up:
This article was originally published in Clinica
Merck KGaA has reorganised its activities in France into one company to be known as Merck Lipha. The reorganisation involves the merging of Merck Clevenot, which manufactures diagnostic reagents and lab equipment, with pharmaceutical manufacturer, Lipha. Jean-Noel Treilles, currently president of Lipha, will head the new company and Karl Heinz Peter, president of Merck Clevenot, will become vice-president.
You may also be interested in...
After urging the US Congress to act on updating Medicare Part D, the Association for Accessible Medicines has welcomed the decision to update Part D by the Centers for Medicare & Medicaid Services of the US Department of Health and Human Services.
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.
“You can’t just live off the brand equity anymore,” warned J&J's Consumer Health's Minoj Raghunandanan during the ‘Advancing Trust in the Self-Care Industry’ webinar co-hosted by the Global Self-Care Federation and HBW Insight. “You’ve got to continue to build that trust between consumers and products day-in day-out.”